FOCUS-PDCA循环法在输血反应上报中的应用*

doi:10.3969/j.issn.1671-2587.2022.01.020

临床输血与检验 ›› 2022, Vol. 24 ›› Issue (1): 88-92.DOI: 10.3969/j.issn.1671-2587.2022.01.020

FOCUS-PDCA循环法在输血反应上报中的应用*

王巍东, 王晶晶, 李闯, 申家辉, 李志强

453003 新乡医学院第三附属医院输血科（王巍东,李闯,申家辉）; 新乡医学院第一附属医院肿瘤科（王晶晶）; 上海交通大学附属第六人民医院输血科（李志强）

收稿日期:2020-09-23 发布日期:2022-01-27
通讯作者: 李志强,男,主任医师,硕士研究生导师,主要从事血液系统疾病诊治与临床输血反应研究,（E-mail）kcb039@126.com
作者简介:王巍东（1982-）男,河南偃师人,主管技师,硕士,主要从事临床输血与管理方面研究,（E-mail）40014131@qq.com

Improving the Reporting of Adverse Reactions with FOCUS-PDCA Cycle in Clinical Blood Transfusion

WANG Wei-dong, WANG Jing-jing, LI-Chuang, et al

Department of Transfusion, Third Affiliated Hospital of Xinxiang Medical College, Henan 453003

Received:2020-09-23 Published:2022-01-27

摘要/Abstract

摘要： 目的探讨FOCUS-PDCA循环法在提高输血不良反应上报中的作用。方法 2015~2018年的输血病例作为对照组,应用FOCUS-PDCA循环法,对2019年本院输血不良反应上报过程进行持续改进。结果通过新的输血不良反应上报制度的建立,设定目标值为100%,使用FOCUS-PDCA循环法,输血不良反应的上报执行率逐步上升至98%。且输血不良反应发生率增至为0.74%,分别与历年相比有统计学差异（χ2=81.64,P<0.05）。结论应用FOCUS-PDCA循环法明显提高了输血不良反应上报执行率,在临床输血质量管理方面起到了重要作用,值得临床推广。

关键词: FOCUS-PDCA循环法, 输血反应, 上报执行率

Abstract: Objective To explore a FOCUS-PDCA cycle approach to improve reporting of adverse reactions to blood transfusion. Methods The FOCUS-PDCA cycle approach was applied to continuously improve the reporting process of adverse reactions associated with transfusion in 2019 versus transfusion cases from 2015 to 2018 in the control group. Results Through the establishment of a novel system for reporting adverse transfusion reactions, the target value was set at 100%. The implementation rate of adverse reactions gradually increased to 98% by FOCUS-PDCA cycle approach. The incidence of adverse reactions increased to 0.74%, with statistically significant differences compared to the previous year (χ2=81.64,P<0.05). Conclusion The application of the FOCUS -PDCA cycle approach significantly improved the execution rate of adverse transfusion reactions reported. It plays an important role in clinical blood transfusion quality management and is worthy of promotion.

Key words: FOCUS-PDCA, cycle, approach, Transfusion, reactions, Report, execution, rate

中图分类号:

R457.1+3

王巍东, 王晶晶, 李闯, 申家辉, 李志强. FOCUS-PDCA循环法在输血反应上报中的应用*[J]. 临床输血与检验, 2022, 24(1): 88-92.

WANG Wei-dong, WANG Jing-jing, LI-Chuang, et al. Improving the Reporting of Adverse Reactions with FOCUS-PDCA Cycle in Clinical Blood Transfusion[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2022, 24(1): 88-92.

参考文献

[1] KARCUTSKIE C A,MEIZOSO J P,RAY J J,et al.Mechanism of injury may influence infection risk from early blood transfusion[J].Surg Infect,2017,18(2):83-88.
[2] MONCHARMONT P,QUITTANÇON E,BARDAY G,et al.Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes[J].Vox Sang,2019,114(4):349-354.
[3] 卫生部医疗服务监管司.三级综合医院评审标准实施细则[EB/OL].(2011-11-25).http://www.nhc.gov.cn/wjw/gfxwj/201304/0404f9cd71764ab29b2365e069cfbf2d/files/02b5187a195c42e0855e4e27445fc2f0.pdf.
[4] 李志强,宫济武.溶血性输血反应与细菌性输血反应处置流程[J].中国输血杂志,2012,25(9):824-825.
[5] 滕方,张燕,孙桂香,等.我国三甲医院输血不良反应发生率的meta分析[J].中国循证医学杂志,2015,15(3): 282-289.
[6] 胡佳林,周浩锋.214例患者输血不良反应临床分析[J].重庆医学,2018,47(8):1068-1069.
[7] 刘红伟,钟国权,林金端.二八法则在医生用血评价管理中的应用[J].临床输血与检验,2016,18(6): 565-568.
[8] 褚晓凌,郭永建.国际输血协会《非感染性输血不良反应监测标准》之解读[J].中国输血杂志,2012,25(8): 812-814.
[9] HARVEY A R,BASAVARAJU S V,CHUNG K W,et al.Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module,United States,2010 to 2012[J].Transfusion,2015,55(4):709-718.
[10] 王秋实,杨巧妮,林强.成人手术患者输血相关呼吸系统不良反应调查分析[J].中国输血杂志,2016,29(12): 1345-1349.
[11] 林强,王秋实,徐昕,等.骨科患者输血不良反应的临床研究[J].中国输血杂志,2017,30(6):617-620.
[12] 田雪,田力,孔玉洁,等.166例输血不良反应的回顾性评估分级研究[J].中国输血杂志,2017,30(4):371-374.
[13] HARVEY A R,BASAVARAJU S V,CHUNG K W,et al.Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module,United States,2010 to 2012[J].Transfusion,2015,55(4):709-718.
[14] SACHAN D,KUMAR A,JOTHIMANI D,et al.Delayed serological transfusion reaction after platelet transfusion due to anti-E[J].Indian J Hematol Blood Transfus,2016,32(suppl 1):287-289.

FOCUS-PDCA循环法在输血反应上报中的应用*

Improving the Reporting of Adverse Reactions with FOCUS-PDCA Cycle in Clinical Blood Transfusion

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 5

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	向东, 范亮峰, 刘曦, 沈伟, 郑皆炜, 谢军华, 王中英, 金沙, 陆琼, 姜跃勤, 张玉宇. 免疫性溶血性输血反应100例分析*[J]. 临床输血与检验, 2022, 24(1): 11-15.
[2]	韦海春, 宁冈, 梁玉君, 梁志东, 郑敏. 重型β地中海贫血患者随机输注RhC、c、E、e血型血液情况的初步研究^*[J]. 临床输血与检验, 2020, 22(6): 621-623.
[3]	周芳竹, 朱传琳, 兰炯采, 张娟. 中药在抑制补体活性及溶血反应中的作用^*[J]. 临床输血与检验, 2019, 21(3): 229-232.
[4]	王丽莉, 杜平. 免疫产生迟发型溶血性输血反应的分析[J]. 临床输血与检验, 2018, 20(2): 185-188.
[5]	杨园园, 林正明. 抗-E抗体导致迟发型溶血性输血反应1例[J]. 临床输血与检验, 2017, 19(6): 639-640.